September 19, 2016 News by Patricia Silva, PhD #ECTRIMS2016 – Brain MRI Scans Can Predict Which Patients Will Progress into SPMS The presence of certain brain and spinal cord lesions can be used to predict if an MS patient with clinically isolated syndrome will progress into relapsing or secondary progressive multiple sclerosis (SPMS) within 15 years. Researchers agree that knowing which patients who will rapidly deteriorate will help physicians tailor both…
September 8, 2016 News by Charles Moore #ECTRIMS2016 – Congress on Latest in MS Research and Treatment Opens Sept. 14 The 32nd annual congress of the European Committee for Treatment and Research in Multiple Sclerosis, widely referred to as ECTRIMS, will kick off on Wednesday,Ā Sept. 14, in London. The four-day eventĀ is partnering this year with the Annual Conference of Rehabilitation in MS Ā (RIMS), the European network for best…
August 19, 2016 News by InĆŖs Martins, PhD MS Progression Slower in People Who Begin Betaseron Therapy at First Signs of Disease, 11-Year Study Says Relapsing multiple sclerosis patients who begin taking Betaferon/Betaseron (interferon beta-1b) immediately after the first MS-related neurologic symptoms appear mayĀ realize slower disease progression thanĀ those who delay treatment, according to aĀ study evaluating the therapy’sĀ effects over a decade in patients enrolledĀ inĀ aĀ Phase 3 clinical trial. The study, “The 11-year long-term follow-up…
August 15, 2016 News by Patricia Silva, PhD Treating MS Soon After Symptoms Appear Can Delay Relapses, Study Says A long-term study underscoresĀ the potentialĀ benefits, especially in terms of relapses,Ā ofĀ multiple sclerosis (MS) patients beginning treatment as soon as possible after symptomsĀ appear ā even before the disease is definitely diagnosed.Ā āThe 11-year long-term follow-up study from the randomized BENEFIT CIS trialā was published in the journal Neurology. Researchers in…
June 22, 2016 News by Patricia Silva, PhD Poor Physical and Cognitive Skills in MS Patients Linked to Cerebral Microbleeds As we age, the risk that small blood vessels will start leaking into brain tissue increases, raising ourĀ risk ofĀ dementia, stroke, and Parkinsonās disease. New research reveals that peopleĀ with multiple sclerosis (MS) also have these so-called cerebral microbleeds, andĀ links them to increasedĀ physical and cognitive disability. When Robert Zivadinov, a professor of…
April 8, 2016 News by Patricia Inacio, PhD Smoking Appears Linked to Brain Abnormalities in People with MS-related Disease, Study Suggests AĀ team of researchers suggested thatĀ cigarette smokingĀ is associated withĀ adverse effects toĀ white matterĀ in the brain, and reportedĀ that smokingĀ may underlie the clinical course ofĀ clinically isolated syndrome, an early and potentially predictive symptom of aĀ progression to multiple sclerosis (MS). The study, āInfluence of cigarette smoking on white matter in patients with…
May 21, 2015 News by admin 11-Year Follow-up of Bayer’s BENEFIT Interferon-beta1b Treatment Reveals Positive Results For MS Patients Results from the BENEFIT11 trial indicate thatĀ early treatment with IFNB-1b leads to improvements inĀ cognition and fatigue in the long-term, as well as sustained employment and favorable magnetic resonance imaging (MRI) outcomes, measured at the 11-year mark. Supported byĀ Bayer HealthCare Pharmaceuticals, the study, titled “Long-term Impact of Early MS Treatment with…
September 23, 2014 News by Patricia Silva, PhD Researchers Reveal Relevance of Microparticle Levels in MS, Clinically Isolated Syndrome Researchers are continuing to make headway in discovering new insights into how MS works, which in turn could lead to next-generation therapies. A new study shows that in the early stages ofĀ multiple sclerosisĀ (MS), plasma micro particles act as biomarkers as well as pathological factors that induce endothelial permeability and…